Clinical Trials
2 trialsNCT05181033 2025-07-25
Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor
National University Hospital, Singapore
Phase 2 Recruiting
NCT03168074 2017-06-16
Phase II Study of Single Agent Lenvatinib
National University Hospital, Singapore
Phase 2 Unknown